Danaher’s stock drop looks like a buying opportunity after it reported a solid quarter

Health, Fitness & Food

In this photo illustration, Danaher Corporation logo seen displayed on a smartphone with the stock market information of Danaher Corporation in the background.
Igor Golovniov | Lightrocket | Getty Images

Life sciences and medical diagnostics company Danaher (DHR) reported better-than-expected earnings and revenue for the fourth quarter. We view the dip in the stock as unjustified and an opportunity.

Articles You May Like

Jane Fonda Reflects on Her Past Eating Disorder: “It’s a Very Lonely Thing”
Meet the scientist who has transformed our understanding of evolution
Covid-19 ‘baby bump’ brought an increased US fertility rate in 2021 — but also record high preterm births
Even One Head Injury Boosts All-Cause Mortality Risk
FDA OKs Elacestrant for ESR1+ Advanced, Metastatic Breast Cancer

Leave a Reply

Your email address will not be published. Required fields are marked *